相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Mo1867 - Shorter Disease Duration is Associated with Higher Response Rates to Vedolizumab in Crohn's Disease but not Ulcerative Colitis: A Multi-Center Consortium Analysis
David Faleck et al.
GASTROENTEROLOGY (2018)
Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy
Christine Olbjorn et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease
Abhijeet Yadav et al.
INFLAMMATORY BOWEL DISEASES (2017)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Bruce E. Sands et al.
INFLAMMATORY BOWEL DISEASES (2017)
Insights on the use of biosimilars in the treatment of inflammatory bowel disease
Michael K. Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
A. Cholapranee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables
C. A. Siegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Personalizing IBD Therapy: The Asian Perspective
Suk-Kyun Yang
DIGESTIVE DISEASES (2016)
Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study
Christopher Ma et al.
INFLAMMATORY BOWEL DISEASES (2016)
Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease
Wan-Ju Lee et al.
INFLAMMATORY BOWEL DISEASES (2016)
Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment
Ben Kang et al.
JOURNAL OF CROHNS & COLITIS (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study
Christopher Ma et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease
E. Safroneeva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease - a SONIC post hoc analysis
J. -F. Colombel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
Guillaume Bouguen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
Johannan F. Brandse et al.
GASTROENTEROLOGY (2015)
Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis
Sanjay K. Murthy et al.
INFLAMMATORY BOWEL DISEASES (2015)
Infliximab Top-Down Strategy is Superior to Step-Up in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease
Yoo Min Lee et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US
Russell Cohen et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
Crohn disease and ulcerative colitis in children: An update for 2014
Daniel A. Lemberg et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2015)
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Jean-Frederic Colombel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres
Michael D. Mandel et al.
DIGESTIVE AND LIVER DISEASE (2014)
Can We Predict the High-Risk Patient?
Jose-Manuel Benitez et al.
DIGESTIVE DISEASES (2014)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease
Thomas D. Walters et al.
GASTROENTEROLOGY (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Duration of Disease May Predict Response to Infliximab in Pediatric Ulcerative Colitis
Sabina A. V. Mir et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project
Isabelle Cleynen et al.
GUT (2013)
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S. Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn's Disease
Francesca Zorzi et al.
PLOS ONE (2013)
Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis
Claudia Camila Dias et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease
Monia Marchetti et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2013)
Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Inflammatory bowel disease: A Canadian burden of illness review
Angela Rocchi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Clinical Risk Factors for Complicated Disease: How Reliable Are They?
Camille Zallot et al.
DIGESTIVE DISEASES (2012)
Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years
Tine Jess et al.
GASTROENTEROLOGY (2012)
Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health
Laurent Peyrin-Biroulet et al.
GUT (2012)
Response to biologic therapy in Crohn's disease is improved with early treatment: An analysis of health claims data
David T. Rubin et al.
INFLAMMATORY BOWEL DISEASES (2012)
Ulcerative colitis as a progressive disease: The forgotten evidence
Joana Torres et al.
INFLAMMATORY BOWEL DISEASES (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies
Mi Jin Kim et al.
ACTA PAEDIATRICA (2011)
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease
M. A. Kamm et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Transitioning the Adolescent Inflammatory Bowel Disease Patient: Guidelines for the Adult and Pediatric Gastroenterologist
Yvette Leung et al.
INFLAMMATORY BOWEL DISEASES (2011)
A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization
Abderrahim Oussalah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
Stefan Schreiber et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease
Marla Cindy Dubinsky
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
M. J. L. Romberg-Camps et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Severity of Inflammation as a Predictor of Colectomy in Patients With Chronic Ulcerative Colitis
Marco M. Hefti et al.
DISEASES OF THE COLON & RECTUM (2009)
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort
R. K. Weersma et al.
GUT (2009)
Long-term Outcome of Maintenance Infliximab Therapy in Children with Crohn's Disease
Jeffrey S. Hyoms et al.
INFLAMMATORY BOWEL DISEASES (2009)
Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms
Marian Pfefferkorn et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
Inger Camilla Solberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease
Peter Laszlo Lakatos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Marla C. Dubinsky et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Immunopathogenesis of inflammatory bowel disease
David Q. Shih et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
S. Kugathasan et al.
GUT (2007)
Maintenance therapy with certolizumab pegol for Crohn's disease
Stefan Schreiber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Risk factors and indications for colectomy in ulcerative colitis patients are different according to patient's clinical background
Motoaki Kuriyama et al.
DISEASES OF THE COLON & RECTUM (2006)
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
P Rutgeerts et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
G Van Assche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery
J Cosnes et al.
GUT (2005)
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype
IDR Arnott et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis
T Ahmad et al.
TISSUE ANTIGENS (2003)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Distinct inflammatory mechanisms mediate early versus late colitis in mice
DM Spencer et al.
GASTROENTEROLOGY (2002)
Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine an colonic motility in patients and healthy subjects
B Coulie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
分享论文
